EXPE

Expedia Group
D

EXPE

Arincen83/100B

Expedia Group executives and insider trading

Ariane Gorin reported no open-market purchases or sales over the last twelve months.

Over the last twelve months Expedia Group's insiders sold 31,522 shares for 8.51M USD in 12 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
12
Shares sold
31,522
Value sold
8.51M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
3.88M USD
0
6 months
5.19M USD
0
1 year
8.51M USD
0
2 years
32.81M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Robert John Dzielak Chief Legal & People Officer and Corporate Secretary5518,9344.86M USD—24 Aug 2026106,635
Craig A Jacobson Director—6,1331.84M USD—13 Aug 202629,833
Lance A. Soliday Senior Vice President & Chief Accounting Officer535,4551.55M USD—18 Aug 202612,006
Madhumita Moina Banerjee Director—1,000258.00K USD—1 Dec 20253,634

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
24 Aug 2026Robert John DzielakSale1,004335.00336.34K USD104,331Form 4
18 Aug 2026Lance A. SolidaySale2,810323.65909.46K USD12,006Form 4
17 Aug 2026Robert John DzielakSale2,000330.50661.00K USD105,335Form 4
13 Aug 2026Craig A JacobsonSale3,133328.521.03M USD29,833Form 4
11 Aug 2026Robert John DzielakSale3,003315.00945.95K USD103,829Form 4
5 Jun 2026Robert John DzielakSale4,702233.001.10M USD105,448Form 4
26 May 2026Lance A. SolidaySale940221.86208.55K USD14,083Form 4
4 Mar 2026Robert John DzielakSale8,225220.821.82M USD102,480Form 4
1 Dec 2025Madhumita Moina BanerjeeSale1,000258.00258.00K USD2,916Form 4
25 Nov 2025Lance A. SolidaySale856256.93219.93K USD10,806Form 4
21 Nov 2025Lance A. SolidaySale849248.08210.62K USD11,662Form 4
13 Nov 2025Craig A JacobsonSale3,000271.55814.65K USD30,858Form 4
20 Aug 2025Lance A. SolidaySale852205.88175.41K USD12,036Form 4
19 Aug 2025Craig A JacobsonSale3,000207.78623.33K USD33,858Form 4
13 Aug 2025Robert John DzielakSale2,658205.57546.40K USD74,417Form 4

Common questions about Expedia Group's executives and insiders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.